Mercer University is a private research university with its main campus in Macon, Georgia. Founded in 1833 as Mercer Institute and gaining university status in 1837, it is the oldest private university ...

During the past decade, Mercer University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercer University" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "American Regent, Inc." with 1 trials sponsored, "CVRx, Inc." with 1 trials sponsored, "Janssen Scientific Affairs, LLC" with 1 trials sponsored and "Ono Pharma USA Inc" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercer University" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator and "ResMed Foundation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Mercer University" are "HIV Infections" (3 trials), "HIV" (2 trials), "Heart Failure" (2 trials), "Acquired Immunodeficiency Syndrome" (1 trials) and "Acute Decompensated Heart Failure" (1 trials). Many other conditions were trialed in "Mercer University" in a lesser frequency.

Most popular intervention types in "Mercer University" are "Drug" (8 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "E/C/F/TAF" (2 trials), "BAROSTIM NEO® System" (1 trials), "COBI" (1 trials), "D/C/F/TAF FDC" (1 trials) and "DRV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercer University" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Mercer University". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Mercer University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mercer University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".